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Reston virus (RESTV; *Filoviridae*: *Ebolavirus*: *Reston ebolavirus* \[[@B1]\]) was discovered in 1989--1990, during a highly lethal viral hemorrhagic fever epizootic among crab-eating macaques (*Macaca fascicularis*) in primate-holding facilities in Reston, Virginia (1989 and 1990), Philadelphia, Pennsylvania (1989), and Alice, Texas (1989), USA. The affected animals were traced to a single primate export facility in the Philippines ([@B2][@B3][@B5]). RESTV reemerged in crab-eating macaques imported from the same facility in 1992 in Siena, Italy ([@B6], [@B7]), and in 1996 in Alice, Texas, USA ([@B8][@B9][@B11]), and was found in sick domestic pigs (*Sus scrofa*) and unspecified nonhuman primates in the Philippines in 2008 ([@B12]) and 2015 ([@B13]), respectively.

RESTV isolate sequence data are sparse ([@B14]), and only a single complete ([@B15]) genome (Reston virus/M.fascicularis-tc/USA/1989/Philippines89-Pennsylvania; RefSeq no. NC_004161 \[[@B16]\]) is available from the 1989--1990 epizootic. We sequenced RESTV AZ-1435, an isolate obtained from the spleen of a crab-eating macaque with signs of respiratory infection sampled during the 1990 Reston, Virginia, USA, episode of the 1989--1990 outbreak ([@B17], [@B18]). RESTV AZ-1435 was isolated by inoculating MA-104 cells with 10% spleen homogenate, followed by passage of MA-104 cell supernatant onto Vero E6 cells ([@B17]). We further passaged this sample by infecting Vero E6 cells and harvesting supernatant.

The virus was inactivated with Trizol LS (Thermo Fisher Scientific), and RNA was extracted as described previously ([@B19]). rRNA removal (low-input Ribo-Zero, Illumina) was performed prior to cDNA synthesis. cDNA libraries for sequencing were prepared using the Ovation RNA-Seq version 2 system (NuGEN Technologies) and the Ultralow DR (directional read) multiplex system (NuGEN Technologies) following the manufacturers' recommendations. After single-primer isothermal amplification (SPIA, NuGEN Technologies), cDNA was purified using Agencourt RNAClean XP beads (Beckman Coulter, Inc. Life Sciences), sheared, and sequenced via paired-end (2 × 100 bp) in rapid chemistry mode on a HiSeq 2500 sequencing system (Illumina). SMARTer rapid amplification of cDNA ends (RACE) 5′/3′ kit (Clontech Laboratories, Inc.) was used to amplify the 5′ end of RNA. The 3′ end was amplified by adding adapter oligonucleotides with T4 RNA ligase I (New England BioLabs) and reverse transcriptase (RT)-PCR. RT-PCR products were cloned into pGEM T-easy vectors (Promega) for sequencing.

Trimmomatic ([@B20]), was used to trim reads for quality and length prior to assembly. Read quality was assessed pre- and post-trimming using open source FastQC version 0.11.5 software (Babraham Bioinformatics, <http://www.bioinformatics.babraham.ac.uk/projects/fastqc>). Reads were mapped to the RESTV reference genome (RefSeq no. NC_004161) using the Burrows--Wheeler aligner MEM (BWA-MEM) algorithm ([@B21]). Variants were identified using genome analysis toolkit (GATK) best practices ([@B22], [@B23]) and were manually inspected with Integrative Genomics Viewer (IGV) ([@B24], [@B25]). A final sequence was identified by comparison to NC_004161.

The RESTV AZ-1435 genome differs from the Pennsylvania genome at few locations, supporting previous investigations indicating that the 1989--1990 U.S. episodes were directly connected. Our data support the hypothesis that both RESTV isolates share an ancestor virus that was exported to all affected U.S. locations.

Accession number(s). {#s1}
--------------------

The GenBank accession number of RESTV AZ-1435, now designated Reston virus/M.fascicularis-tc/USA/1989/Philippines89-AZ1435 based on current filovirus nomenclature standards ([@B26]), is [KY008770](https://www.ncbi.nlm.nih.gov/nuccore/KY008770).
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